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89The primary goal of translational research is to generate and apply knowledge that
can improve human health. Although research conducted within the confines of a
single discipline has helped us to achieve this goal in many settings, this unidiscipli-
nary approach may not be optimal when disease causation is complex and health
decisions are pressing. To address these issues, we suggest that transdisciplinary ap-
proaches can facilitate the progress of translational research, and we review publi-
cations that demonstrate what these approaches can look like. These examples
serve to (1) demonstrate why transdisciplinary research is useful, and (2) stimulate
a conversation about how it can be further promoted. While we note that open-
minded communication is a prerequisite for germinating any transdisciplinary
work and that epidemiologists can play a key role in promoting it, we do not propose
a rigid protocol for conducting transdisciplinary research, as one really does not
exist. These achievements were developed in settings where typical disciplinary
and institutional barriers were surmountable, but they were not accomplished with
a single predetermined plan. The benefits of cross-disciplinary communication are
hard to predict a priori and a detailed research protocol or process may impede
the realization of novel and important insights. Overall, these examples demonstrate
that enhanced cross-disciplinary information exchange can serve as a starting point
that helps researchers frame better questions, integrate more relevant evidence,
and advance translational knowledge more effectively. Specifically, we discuss ex-
amples where transdisciplinary approaches are helping us to better explore, assess,
and intervene to improve human health. (Translational Research 2016;-:1–12)90
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214INTRODUCTION
The primary goal of translational biomedical research
is to elucidate the determinants of disease and apply
this knowledge to improve clinical or population
health practices. Epidemiologists have been success-
ful in advancing this goal, particularly in the context
of conditions with causal factors that have consis-
tently detectable marginal associations. However, in
the context of etiologically heterogeneous complex
disease, causal factors may not have reproducibly
detectable marginal associations because these dis-
eases have multiple interacting determinants. As a
result, progress in this area has been much slower.
Here, we take the perspective of epidemiologists and
hope to generate further discussion by exploring a
general approach for increasing our ability to address
multifactorial health problems. Specifically, we advo-
cate that epidemiologists take a transdisciplinary
approach, and propose that enhancing the opportunity
for cross-disciplinary information exchange can help
by making relevant perspectives from multiple
distinct fields available for scientific reasoning at
each stage of the research process, but perhaps most
importantly at the outset of defining a problem and
designing a research strategy. This increases our chan-
ces of realizing information synergies, thereby allow-
ing us to frame better questions, gather more
comprehensive data, and better exploit existing infor-
mation to guide health decisions.
This general approach addresses the key issues iden-
tified in two sets of recent commentaries concerning the
future of epidemiologic research. The first group of
commentaries proposes that innovative thinking will
be central to progress in epidemiology and translational
research (particularly in the current age of big data),1-3
and the second group posits that integrated approaches
can streamline the development of effective
interventions.4-7 Here, we extend this discussion by
exploring specific theoretical issues and examples that
illustrate how cross-disciplinary information exchange
has provided novel insights into disease processes, led
to more complete knowledge of causation, and thereby
spurred the development of more effective interven-
tions. Thus, the overall purpose of this paper is to reveal
the underappreciated utility of transdisciplinary
research and fuel discussion about how it can be
fostered.November 2016  9:24 pm  ce
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322The examples provided here clarify how enhanced
communication between fields can cultivate creative ap-
proaches that make translational research both more
effective and efficient. They also emphasize the often
underappreciated advantages of teamwork.8 These ex-
amples do not argue for the development of a single
pipeline for the conduct of transdisciplinary research
or even that it is possible to know a priori how to design
ensemble research strategies for all contexts. We also
recognize that transdisciplinary research often involves
difficult challenges,9 and it cannot be forced. However,
we propose that we can spur the development of produc-
tive transdisciplinary approaches if we create research
and training environments that encourage cross-
disciplinary information exchange. By extension,
failing to take measures to increase our cross-
disciplinary fluency will likely impede, or even prevent,
the development of solutions to many human health
problems. Stated differently, traditional silo-based
research can only address a limited number of incom-
plete questions.
As the examples here demonstrate, open-minded
cross-disciplinary communication can yield useful but
unpredictable results. Before researchers begin talking
to people from other fields (or at least start reading their
papers), it will often not be clear how different disci-
plines may help each other address a given problem.
In addition, it will usually not be clear beforehand if
the help will come in framing questions (the beginning),
analytic methods (the middle), or information integra-
tion and intervention (the end). This communication
could result in the cross-disciplinary transfer of a single
critical piece of information or it could generate a long-
term symbiotic relationship between researchers. The
nature of this communication and character of its bene-
fits are inherently unpredictable. Therefore, we will not
unnecessarily constrain this process by proposing the
use of rigid constructs or specific protocols.
Unfortunately, the utility of cross-disciplinary
communication is frequently overlooked although it
has already produced significant advances. For
example, how long would it have taken to reduce
cholera transmission if John Snow had not: (1) thought
beyond some existing concepts in his discipline (mi-
asma), (2) looked for patterns in new ways (his maps),
and (3) worked with relevant people from outside his
immediate field (Rev. HenryWhitehead)?10 Essentially,
the utilization of information from multiple disciplines
throughout the research process creates a transdisci-
plinary approach11,12 that can extend knowledge
beyond the limitations of the contributing disciplines.
Transdisciplinary research does not refer to the
combination of fully formed ideas from distinct fields
(multidisciplinary research), or the integration of ideasREV 5.4.0 DTD  TRSL1114_proof  25from distinct fields (interdisciplinary research), rather
it refers to the generation and utilization of research
frameworks and ideas that could not come from, or fit
into, any one field.11,13 This emergent property of
transdisciplinary translational research can enable us
to: (1) explore widely, (2) assess diversely, and (3)
intervene effectively in our efforts to promote human
health. These 3 areas provide the framework for our
discussion below.
TRANSDISCIPLINARY PERSPECTIVES CAN HELP US
GENERATE BETTER HYPOTHESES
A key to getting better answers is asking better ques-
tions, and transdisciplinary perspectives can generate
hypotheses that unidisciplinary perspectives might
otherwise miss. If we utilize a fuller set of scientific per-
spectives, and tools from more than one discipline, we
can frame critical questions that are not apparent from
the data and tools of a single discipline. On the other
hand, if we exclusively use canonical exploratory
methods, we will define relatively simple questions
that will likely fail to identify many of the complex phe-
nomena that lead to health problems.
Example: exploratory research in a single discipline
often fails in the context of complex disease.
‘‘.the problem of identifying and quantifying
multiple component causes of disease is one of
the most basic limitations in modern epidemi-
ology’’
Paolo Vineis and David Kriebel14
In population health and medicine, we often employ
simple descriptive epidemiology techniques to generate
hypotheses about the causes of illness and disease15 (eg,
univariate analyses from surveillance data, frequency
tables, and histograms). Analytic epidemiology tech-
niques can then be used to test these hypotheses, cor-
recting for potential biases.15 This two-step process is
foundational to epidemiology, but its effectiveness can
be limited when the first step is insufficiently informa-
tive. Stated differently, if the relevant causal factors
do not have detectable marginal associations, then stan-
dard descriptive epidemiology techniques may not
effectively direct our subsequent efforts.
Most epidemiology training focuses on analytic
epidemiology and encourages the evaluation of effect
modification (interaction) only if it is suspected a priori.
This rule of thumb makes sense in the context of stan-
dard statistical models, because with these methods,
screening for all possible interactions is at best problem-
atic and at worst impossible. Therefore, if a critical
cofactor is not suspected to be an effect modifier, it is
not usually addressed in standard epidemiologic inves-
tigations. The ability of a cofactor to have importantNovember 2016  9:24 pm  ce
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Fig 1. Visualization techniques reduce jargon-based barriers to cross-disciplinary communication. Visual infor-
mation summaries can stimulate productive conversation in transdisciplinary teams by helping researchers to
reason with relevant factors that are beyond their individual disciplinary expertize. In this example, the putative
causal factors in the etiology of a disease are summarized in a jargon-free visual schematic. Discussing this sche-
matic allows the team to access additional relevant information from the collaborators (ie, factor 7 may provide an
intervention opportunity). In this way, the team identified a previously unrecognized key modifiable factor
although no individual had enough information to think of it on their own.
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430effects, however, is not contingent on our ability to sus-
pect its role a priori. Therefore, we need to develop
exploratory methods to identify putative component
causes16 whose etiologic role is not evident from mar-
ginal associations. A variety of potentially useful new
methods can be found in fields where techniques for
analogous problems have already been developed (eg,
genetics, computer science, economics, and ecology).
Such methods can advance complex disease research
by expanding descriptive epidemiology beyond histo-
grams and correlations, to include methods capable of
generating novel multifactorial hypotheses.
An example of one such tool is multifactor dimension-
ality reduction (MDR), a machine learning method that
explores all possible combinations of categorical vari-
ables to identify combinations that best associate with
the phenotype of interest.17,18 This method was
developed by geneticists to detect gene-gene and gene-
environment interactions that are associated with a
phenotype, and it has demonstrated great utility in this
role.17-26 Thus, this method, perhaps in combination
with other machine learning techniques,27,28 can be
used as a tool to identify multifactor patterns associated
with disease. For example, researchers have used MDR
to identify putative gene-environment interactions inREV 5.4.0 DTD  TRSL1114_proof  25the development of lung cancer (predictive single nucle-
otide polymorphisms [SNPs] differ by smoking status),29
and childhood asthma (several SNPs interact with indoor
dampness).30 Additional strategies for detecting multi-
factor patterns associated with disease continue to be
developed in genetics,31-33 and techniques such as these
can extend our capacity to identify combinations of
factors that are linked to disease risk.
Another promising set of approaches from computa-
tional biology leverages visual data representations to
help translate complex patterns into specific etiologic
questions.34,35 Visual methods may be of particular
relevance in the development of transdisciplinary
discovery epidemiology because they reduce jargon-
based barriers to cross-disciplinary communication
(Fig 1), by replacing field-specific terminology with
broadly-accessible visual aids. Additional nonstandard
computational tools, such as agent-based models and
other complex systems models, may be useful for
learning about multifactor causes and system properties
when disease risk is modulated bymultiple nonlinear in-
teractions that vary temporally.36-38 Furthermore,
establishing transdisciplinary teams can promote
communication between diverse subject matter experts
to advance the development of new complex systemsNovember 2016  9:24 pm  ce
Q9
Table I. A transdisciplinary advance in analytic
epidemiology: directed acyclic graphs
Directed acyclic graphs (DAGs) adapted from computer science
have:
1. Helped us to better identify adjustments that introduce rather
than reduce bias44
2. Provided a general analytic framework that can explain the
‘‘birthweight paradox,’’ and backs up our common sense
notion that trials of prenatal smoking to reduce infant mortality
are not a good idea45
Translational Research
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530models.39 These models can allow researchers to think
about the relationships between putative causal factors
frommultiple fields in novel ways. Such methods create
a unique opportunity to develop the multilevel hypothe-
ses that are needed to address complex health problems.
Of course, thoughtful trials and discussion are required
to better clarify the strengths and weaknesses of these
nontraditional approaches. This process is already under-
way forMDR23-28 and agent-basedmodels.40-43 Because
nontraditional discovery epidemiology methods (eg,
MDR) are prone to bias, as are all descriptive
epidemiology methods (eg, unadjusted associations),
validation with traditional analytic epidemiology
models is important. Furthermore, even analytic
epidemiology approaches that properly account for
known confounding and biases are limited in their
ability to infer causality. Therefore, experimental,
biological, and implementation research strategies will
continue to be crucial for validating and characterizing
the causal relationships suggested by any observed
statistical associations.
We note that it is not surprising that transdisciplinary
approaches can generate advances in descriptive epide-
miology because in recent years techniques from other
fields have enhanced the practice of analytic epidemi-
ology. In particular, directed acyclic graphs (DAGs)
from computer science have advanced our ability to
communicate causal structures and identify bias, thus
allowing us to build better analytic epidemiology
models (Table I).46 Here, we simply note that methods
from other fields might help us advance descriptive
epidemiology as well. Importantly, if we fail to utilize
new pattern finding algorithms for discovery epidemi-
ology, we will likely miss opportunities to identify
modifiable component causes of disease.531
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538TRANSDISCIPLINARY PERSPECTIVES CAN HELP US
BETTER ASSESS AND INTERPRET EVIDENCE
Transdisciplinary perspectives can help us to gather
and utilize more relevant and comprehensive evidence
for vetting putative etiologic factors. This allows us to
better address our concerns about potentially
misleading findings.47 By including diverse types ofREV 5.4.0 DTD  TRSL1114_proof  25data and encouraging multiple modes of assessment,
transdisciplinary perspectives can rigorously evaluate
the strength of evidence supporting a given hypothesis.
The process of including more and diverse approaches
that are encompassed by a transdisciplinary paradigm
can result in a detailed understanding of the current un-
certainties and thus clarify for decision makers which
courses of action (or inaction) are most reasonable in
light of the existing knowledge. It can also clarify for re-
searchers what additional evidence is most needed to
advance our understanding of disease etiology and po-
tential interventions. In short, transdisciplinary ap-
proaches can improve our decision making by
enhancing our ability to reason with imperfect and
incomplete evidence from many sources.
Example: transdisciplinary information allows for diverse
convergent validation of findings. Genome Wide Associ-
ation Studies (GWAS) are expensive endeavors and re-
searchers would like to increase the usable knowledge
gained from these studies to learn more about disease
etiology and intervention options. It is becoming recog-
nized that, when utilized in isolation, GWAS analyses
have a variety of weaknesses that can hinder the discov-
ery of genetic risk factors.48-54 Essentially GWAS, like
all epidemiologic analyses, are prone to both type-1 and
type-2 error, as well as the influence of unrecognized
biases. However, if GWAS data is systematically
evaluated in the context of relevant evidence from
diverse areas, it can be part of a larger process that
more effectively discovers and vets genetic risk
factors for disease. For example, DiCE (Diverse
Convergent Evidence) is an evidence integration
process that combines information from observational
association studies, bioinformatics, and laboratory
experiments to yield a metric that reflects the
likelihood that a given genetic factor is involved in the
disease pathophysiology.54 As a proof of principle,
this metric identified the role of Hemoglobin S in
severe malaria resistance54-56 and the role of PPAR-
gamma in type 2 diabetes54,57-59 when standard
GWAS validation criteria alone failed to detect these
etiologically relevant factors. DiCE can also highlight
potential false-positive findings in GWAS analyses,
including those that reach canonical thresholds for
statistical significance, and suggest future research to
address the ambiguous evidence. Overall, DiCE
allows more diverse evidence to enter the process of
determining what leads to follow and how to follow
them. This promotes well-informed decisions and
faster knowledge acquisition.
Example: transdisciplinary approaches allow us to work
with disparate inconclusive evidence. How can we even
begin to ameliorate a problem with as many potential
causes as the obesity epidemic? Again, a broadNovember 2016  9:24 pm  ce
Table II. Cochrane Reviews63 can convert literature that is unwieldy and inaccessible into evidence that is
widely accessible and relevant to decision makers*
Many doctors and patients may ask:
Can vitamin C supplements prevent or treat the common cold (viral respiratory infections)?
Potential utility Unclear utility Feasibility Safety
Strong evidence
suggests that regular
vitamin C
supplementation can
reduce the duration
and severity of
common colds that
occur
The evidence is
inconclusive as to
whether vitamin C can
prevent the common
cold or reduce
symptoms if it is
started after cold
onset
Inexpensive Thought to be without
adverse effects.
*Information extracted froma scientific abstract and plain language summary that are freely available (in several languages) at theCochrane
website.64
Translational Research
6 Ciesielski et al - 2016
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645perspective and systematic information integration can
be useful. In 2010, the Institute of Medicine developed
a framework to promote this type of translational
approach for combating obesity: the IOM L.E.A.D.
framework.60 And recently, Chatterji et al. discussed
the application of this type of approach in New York
City’s policy decisions regarding fat and calorie
information for restaurant food.61 In this framework,
researchers: A) Locate Evidence, B) Evaluate It, C)
Assemble It, and D) Inform Decisions. The structure
for this translation process reflects our need to make
policy decisions when there are many disparate pieces
of relevant but inconclusive evidence. Imperfect
evidence may only provide decipherable guidance in
our research and intervention decisions, if it is
considered in its totality. Narrow assessments of the
evidence from one field could prove misleading or just
plain false. Thus, the structure and purpose of
L.E.A.D. is analogous to DiCE, although it is more
directly focused on implementation.
Example: multidisciplinary teams can facilitate
information synthesis and decision making. Physicians
need to quickly learn what the research evidence sug-
gests should be done for their patients. If that volumi-
nous information is not comprehensively and cogently
distilled in an ethical manner, then physicians cannot
effectively use it to guide patient care decisions. For
over 20 years, the nonprofit Cochrane Collaboration
has been using a network of diverse working groups to
synthesize medical research information and increase
its utility in decision making.62 By promoting input
from a broad array of sources, the available evidence
and its quality have been considered and organized to
address the types of questions that physicians and
patients ask. For example, this approach has translated
the complex literature on vitamin C and the common
cold into actionable information (Table II).REV 5.4.0 DTD  TRSL1114_proof  25Example: transdisciplinary approaches can clarify
research and intervention priorities. How canwe properly
allocate limited research, remediation, and policy efforts
to the environmental chemicals that pose the greatest risk
to human health? This situation represents another
instance where there is incomplete and nondefinitive in-
formation and a need to advance knowledge quickly to
minimize human health problems. One effective strategy
can be found in the IARC monographs.65 In this
approach, multidisciplinary IARC working groups are
assembled to discuss 4 aspects of a given exposure: (1)
the potential for human exposure, (2) the evidence for
association with cancer in humans, (3) the evidence for
causation of cancer in animals, and (4) relevant
mechanistic/toxicokinetic evidence. This broad scope
of information is then converted by a cross-disciplinary
consensus building process into a carcinogenicity
assessment (eg, probably not carcinogenic, not
classifiable, possibly carcinogenic, probably
carcinogenic, and carcinogenic). Recently, the National
Toxicology Program (NTP) developed a similar general
strategy for integrating human, animal, and in vitro
evidence in chemical assessments.66 The NTP also
makes relevant evidence available for alternative
integration analyses by compiling it into publically
accessible databases (eg, CEBS, DrugMatrix, and
ToxFX).67 Overall, these transdisciplinary approaches
can highlight the largest potential problems based on
the available evidence and simply convey this
information to both researchers and decision makers.
These examples indicate that more comprehensive
and integrated information can allow for improved vali-
dation of potential risk factors and enhanced character-
ization of health problems. The long-standing
transdisciplinary approaches (eg, IARC monographs
and Cochrane Collaboration) provide evidence that
these strategies are very useful and the newer techniquesNovember 2016  9:24 pm  ce
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proaches can be further optimized for efficiency.703
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DEVELOP AND COORDINATE INTERVENTIONS
Discipline-specific strategies can limit our ability to
develop policies and interventions that improve human
health. For example, imagine our goal was to fill a barrel
with water and keep it filled. If the barrel has a hole in it,
how would we best coordinate the efforts of a cooper
with that of a person getting water from a well? No mat-
ter how hard each individual works, their efforts will be
inefficient or even ineffective unless they are applied in
the right order. The development of effective interven-
tions can suffer from similar issues.
Example: interventions can be more effective when
etiologic characterization is transdisciplinary. Chemical
exposures, social exposures (neighborhood and family
interaction styles), genetics, educational strategies,
and nutrients can individually be evaluated for their as-
sociation with neurodevelopmental outcomes. These
variables may be studied separately by environmental
epidemiologists, social epidemiologists, geneticists,
developmental pediatricians, neuropsychologists, and
nutritional epidemiologists, but if they work in isola-
tion, information about how to most effectively inter-
vene is likely to be obscured. How can you
characterize the relationship between lead exposure
and adverse neurodevelopmental outcomes without
considering how psychosocial factors may generate po-
tential confounding and other biases?68 Also, what good
is an educational intervention if the child is still exposed
to lead because the home is not properly remediated or
the source of exposure remains unidentified?
Educational, social, medical, and environmental
interventions can fail or they can be synergistic.
Understanding the relationships between component
causes from a variety of traditionally separate fields
can clarify the overall public health problem and
intervention possibilities, and this principle has
become a driving factor behind the emerging concept
of ‘‘exposome’’ research.69,70
Example: moving from genes or environment, past
genes and environment, to genes with
environment. Studying genetic and environmental fac-
tors together can help us to avoid missing causal fac-
tors.71 The effect of each may depend on the context
defined by the other, and thus some causal factors
may not be detected by looking only at their marginal
associations (note that here we are referring to
environmental factors in the broadest sense:
xenobiotic exposures, social/psychosocial factors,
nutrition, etc.). Even when a marginal association is
detectable, broader consideration of genetic andREV 5.4.0 DTD  TRSL1114_proof  25environmental variables taken together can illuminate
the mechanisms that create this marginal association,
and provide information about etiologic subtypes that
may benefit from distinct interventions.72,73
Furthermore, finding an isolated genetic cause of
disease may not suggest obvious interventions but if a
genetic factor is found to interact with a modifiable
environmental factor, then knowledge of the
environmental factor can create a prevention or
treatment opportunity. For example: children with
genetic disruptions of phenylalanine hydroxylase
function (phenylketonuria) can avoid many adverse
health consequences by eating phenylalanine-limited
diets that would not be optimal for other children.74-76
Example: diverse perspectives allow us to handle
etiologies that change in response to intervention. How
can we design interventions that promote stable positive
changes in complex dynamic systems when the effect of
the same action may vary temporally? RCTs and exper-
iments are ideal for learning about single factors in sys-
tems that you can randomize and control, but are less
useful when multiple dynamic nonlinear interactions
are modulating disease risk. Some of the computational
tools mentioned above (eg, agent-based modeling) may
be useful for learning about how complex systems react
to interventions, and thus they may also be useful for
developing strategies that have consistently positive
impacts.36,37 These methods can allow us to ask
important novel questions. Would a combination of
interventions work well? Do certain policies only have
a high probability of success in specific contexts? Can
multifactorial interventions or contingency algorithms
generate better outcomes in these settings? Along
these lines, the Cancer Intervention and Surveillance
Modeling Network (CISNET)77 has developed a
simulation process that leverages clear modeling
assumptions and comparison of results from multiple
simulations to acquire convergent evidence that
highlights putative causal factors. Importantly,
whatever is learned from complex intervention
simulations and the careful observation of new
interventions, can be fed back into an evolving
knowledge base for guiding future research and
interventions.78,79 Overall, broad transdisciplinary
approaches are essential to better coordinate both our
knowledge and efforts (Fig 2).
EPIDEMIOLOGISTS CAN PLAY A KEY ROLE IN
ADVANCING TRANSDISCIPLINARY APPROACHES
Epidemiologists are well positioned to facilitate
transdisciplinary translational research78,81 because
good epidemiology training provides a familiarity
with a broad range of causal factors, and makes
practitioners aware of the ‘‘big picture’’. In fact, manyNovember 2016  9:24 pm  ce
w
e
b
4
C
=
F
P
O
Fig 2. Transdisciplinary approaches coordinate evidence to generate more useful knowledge. Cross-disciplinary
cooperation allows us to see how information from multiple sources can fit together to build our understanding of
health issues. ‘‘Science is built up with facts, as a house is with stones. But a collection of facts is no more a science
than a heap of stones is a house.’’ – Jules Henri Poincare,80 p. 127.
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Table III. Simple ways that epidemiologists can promote transdisciplinary translational research*
A Incorporate more nonepidemiology concepts and knowledge into epidemiology training
1) Accept students and postdocs who have diverse prior training outside of epidemiology
2) Include nonepidemiology experiences in doctoral training
(eg laboratory, clinical, or policy rotations)
3) Encourage epidemiology students to do postdoctoral training in complementary areas
(eg physiology, demography, public policy, computer science, regulatory agencies, etc.).
B Diversify traditional epidemiology working environments
1) Present and discuss epidemiologic research at disease-specific conferences.
2) Hire individuals who trained in more than one area, or have a unique background outside of epidemiology (these individuals will share
an overlapping vocabulary with people from a separate discipline thus expanding the ‘‘fluency’’ of the epidemiology department).
3) Explain and demonstrate the value-added of including epidemiologists in translational team science to the wider scientific
community.78,81
4) Invite basic researchers, clinicians, and policy experts to speak in epidemiology departments.
5) Develop proactive outreach mechanisms for embedding epidemiologists in clinical and basic science departments to promote
collaboration.
6) Create a multidisciplinary seminar/discussion series to promote information integration and collaboration by focusing on a specific
health issue at each meeting and advertising widely.
7) Offer small pilot funds for projects that access/integrate information from other fields to promote the development of proposals for
extramural funding.
8) Read papers from other disciplines that analyze large complex datasets to better harness diverse perspectives for crucial insights.92
*It is possible that structural changes in research institutions and funding sourcesmight further promote transdisciplinary thinking and the success
of team science oriented researchers, but the small steps listed here are achievable in the near term and capable of informing potential next
steps. In addition, the epidemiologists that experiment with these small steps could serve as key resources in the development of large-scale
transdisciplinary efforts such as the NIH’s Clinical and Translational Science Awards program.93 Beyond exploring the specific actions proposed
here, themost important thing that we all can do to contribute to the conduct of effective transdisciplinary research is to ‘‘hold our knowledge
lightly’’91 and promote a culture of open-mindedness. This receptive yet objective perspective is the oil for transdisciplinary engines. Essentially,
it allows for discussions that illuminate crucial information from many disciplines to generate sound and comprehensive reasoning.
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970epidemiologists are already at the forefront when it
comes to advancing transdisciplinary research, and a
variety of transdisciplines that depend on study design
and analytic principles from epidemiology have
already emerged. For example, epidemiologists are
working with social scientists to understand the social
determinants of health (social epidemiology),82 and ep-
idemiologists are cooperating with toxicologists to
identify chemical etiologic factors (environmental
epidemiology).83 These fields have even been further
combined to allow transdisciplinary insights to flow
from the consideration of social, ecological, and biolog-
ical factors in infectious disease epidemiology.84,85
These are just a few examples but we emphasize that
epidemiology continues to spur synergy in new ways.
Among the newest epidemiology-based transdisciplines
are epigenetic epidemiology86-88 and molecular
pathological epidemiology.89,90 These transdisciplines
are demonstrating that when molecular biologists,
pathologists, and epidemiologists collaborate, they can
evaluate molecular factors in new ways that permit the
identification of etiologic subgroups and the
physiologic mechanisms of disease.
As a group, epidemiologists can further advance this
approach by creating working environments that are
more open to (and capable of) cross-disciplinary con-
versation at all stages of research. This allows for better
integration and application of existing relevant informa-REV 5.4.0 DTD  TRSL1114_proof  25tion that can lead to more complete and useful knowl-
edge,91 and also promotes the more efficient
acquisition of new relevant information. In Table III,
we list specific feasible strategies that can stimulate
transdisciplinary thinking and create opportunities for
intellectual crosspollination through better channels of
communication.CONCLUSION
In this article, we cite examples which demonstrate
that transdisciplinary approaches can cultivate and vet
useful new strategies for dealing with complex health
challenges. These ensemble science methods can
develop whenever we make tangible efforts to improve
cross-disciplinary information exchange, and they
allow us to streamline the development of effective
health interventions. Transdisciplinary approaches can
be as sophisticated as an international team of special-
ists working together in a coordinated fashion, or they
can be as simple as talking more often with people
who have distinct training. The examples presented
here are not intended to provide a blueprint for con-
ducting transdisciplinary work. Instead, they serve to
(1) demonstrate what transdisciplinary insights can
look like and (2) show that these insights can advance
translational research. Overall, we have observed that
being open to cross-disciplinary information exchangeNovember 2016  9:24 pm  ce
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1050is the defining feature of transdisciplinary translational
research, and it has tripartite utility. It helps us to
explore widely, assess diversely, and intervene effec-
tively in complex systems.
This review does not suggest that transdisciplinary
collaboration is a panacea for health research chal-
lenges. However, it does suggest that transdisciplinary
collaboration can help in some situations, and failing
to enhance cross-disciplinary communication and sub-
sequent research approaches may slow down our prog-
ress. That said, many barriers to the conduct of true
transdisciplinary/team science are ingrained in our
research infrastructure, including promotion criteria,
funding, training strategies, and field-specific jar-
gon,13,94-98 and these barriers must be overcome if we
are to realize the benefits of transdisciplinary research.
Importantly, the limitations of unidisciplinary research
may not always be apparent, but if we utilize
transdisciplinary approaches, those shortcomings are
clarified and our ability to improve human health is
enhanced. We cannot answer questions that we do not
ask and we cannot guide our actions with evidence
that we do not assess, but in these tasks
transdisciplinary perspectives can expand the
capabilities of epidemiologists and the translational
research community.1051
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